Revised SPC: Sirturo (bedaquiline fumarate) 100mg tablets

Bedelaquine is now licensed as part of an appropriate combination regimen for pulmonary multidrug‑resistant tuberculosis, in adolescents aged over 12 years. The entire SPC has been updated with information for use in this population

Source:

electronic Medicines compendium